65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01420627 (ClinicalTrials.gov)	January 24, 2014	18/8/2011	EZN-2279 in Patients With ADA-SCID	A Study of EZN-2279 (Polyethylene GlycolRecombinant Adenosine Deaminase [PEG-rADA]) Administered as ...	ADA-SCID;Adenosine Deaminase Deficiency;Severe Combined Immunodeficiency	Biological: EZN-2279;Biological: Adagen	Leadiant Biosciences, Inc.	NULL	Completed	N/A	N/A	All	7	Phase 3	United States